Bellevue Group’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$271K Sell
18,303
-4,797
-21% -$71K 0.01% 118
2025
Q1
$414K Hold
23,100
0.01% 122
2024
Q4
$402K Sell
23,100
-7,900
-25% -$138K 0.01% 128
2024
Q3
$434K Buy
+31,000
New +$434K 0.01% 133